Immunitybio Inc (IBRX NASDAQ) stock market data APIs
$6.6345
-0.06(-0.9%)
as of February 12, 2026
Try our APIs with
free plan!
Immunitybio Inc Financial Data Overview
Price chart is built with
Anychart
ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. ImmunityBio, Inc. is based in San Diego, California.
Prev. Close
6.6345
Open
6.5762
High
6.8342
Low
6.434
52 wk Range
1.83-8.28
Market Cap
6 520 M
Shares Outstanding
985 M
Revenue
82 555 K
EPS
-0.07
Beta
0.017
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Immunitybio Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Immunitybio Inc data using free add-ons & libraries
Get Immunitybio Inc Fundamental Data
Immunitybio Inc Fundamental data includes:
- Net Revenue: 82 555 K
- EBITDA: -244 947 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Immunitybio Inc News
New
A Look At ImmunityBio (IBRX) Valuation After ASCO 2026 Spotlight And Anktiva Growth Momentum
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. ImmunityBio (IBRX) has come back into focus after investo...
Is It Too Late To Consider ImmunityBio (IBRX) After The Recent 181% Monthly Surge?
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. If you are wondering whether ImmunityBio's current share price is giving you a fair deal or...
ImmunityBio Advances Chemotherapy Free Lymphoma Regimen As Global Anktiva Story Grows
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. ImmunityBio launched the ResQ215B Phase 2 trial of a chem...
ImmunityBio (IBRX) Jumps Ahead of Oncology Event
We recently published 10 Big Names With Effortless Double-Digit Gains. ImmunityBio Inc. (NASDAQ:IBRX) was one of the best performers on Monday. ImmunityBio saw its share prices jump by 14.55 percent ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
